Nanomedicine and Neuroprotection in Brain Diseases

Nanomedicine and Neuroprotection in Brain Diseases

Sharma, Aruna; Sharma, Hari Shanker

Elsevier - Health Sciences Division

09/2021

442

Dura

Inglês

9780323901628

15 a 20 dias

1100

Descrição não disponível.
1. Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta protein
2. Glioblastoma: what can we do for these patients today and what will we be able to do in the future?
3. Network Pharmacological Mechanism of Cinobufotalin against Glioma
4. Nanodelivery of Oxiracetam enhances memory, functional recovery and induces neuroprotection following concussive head injury
5. Clinical neurorestorative cell therapies for stroke
6. Nanodelivery of traditional Chinese Gingko Biloba extract EGb-761 and bilobalide BN-52021 induces superior neuroprotective effects on pathophysiology of heat stroke
7. Upregulation of hemeoxygenase enzymes HO-1 and HO-2 following ischemia-reperfusion injury in connection with experimental cardiac arrest and cardiopulmonary resuscitation: Neuroprotective effects of methylene blue
8. Multimodal imaging in the differential diagnosis of glioma recurrence from treatment-related effects: a systematic review and network meta-analysis. A protocol for systematic review and network metaanalysis
9. Manganese nanoparticles induce blood-brain barrier disruption, cerebral blood flow reduction, edema formation and brain pathology associated with cognitive and motor dysfunctions
10. Targeted Therapy with Anlotinib for a Leptomeningeal Spread Recurrent Glioblastoma Patient
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Alzheimer's disease; Anlotinib; Blood-brain barrier; Brain edema; Brain pathology; Cancer cells; Cancer stem cells; Carbon monoxide; Cardiac arrest; Cell therapy; Cerebral blood flow; Cerebrolysin; Chemotherapy; Cinobufotalin; Clinical trial; Concussive head injury; EGb-761; Functional deficit; Gingko Biloba; Glioblastoma; Glioblastoma multiforme; Glioma; Global ischemia; Heat stroke; Hemeoxygenase enzyme; Hyperthermia; Immunotherapy; Leptomeningeal spread; Mesenchymal stem cells; Methylene blue; Mn nanoparticles; Nanomedicine; Nanotechnologies; Nanowired delivery; Network meta-analysis; Network pharmacology; Neuroprotection; Neurorestoration; Olfactory ensheathing cell; Oxidative stress; Oxiracetam; Protocol; Pseudoprogression; Reestablishment of spontaneous circulation; Stem cells; Stroke; Target prediction; TiO2 nanowired delivery; Traumatic brain injury; Treatment resistance; Treatment-related effects